Fifth Eye, a Michigan-based real-time clinical analytics company, announced today that the Food and Drug Administration has granted De Novo classification for its Analytic for Hemodynamic Instability ...

The global hemodynamic monitoring market is experiencing growth due to several factors such as the increase in prevalence of chronic diseases such as heart failure and hypertension and technological ...